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Abstract: Fibromyalgia is a common musculoskeletal syndrome characterized by chronic widespread
pain and other systemic manifestations, which has demonstrated a contribution to higher postoperative
analgesic consumption to other surgeries such as hysterectomies and knee and hip replacements.
The aim of this review is to search current literature for studies considering the impact of fibromyalgia
on clinical outcomes of patients undergoing shoulder surgery. A systematic literature review was
conducted in PubMed/Medline, Embase, and ClinicalTrials.gov in February 2019. Studies were
selected based on the following participants, interventions, comparisons, outcomes, and study design
criteria: adult patients undergoing surgery for shoulder pain (P); diagnosis of fibromyalgia (I);
patients without fibromyalgia (C); outcome of surgery in terms of pain or analgesic or non-steroidal
anti-inflammatory drugs consumption (O); case series, retrospective studies, observational studies,
open-label studies, randomized clinical trials, systematic reviews and meta-analyses were included (S).
Authors found 678 articles, of which four were found eligible. One retrospective study showed that
patients with fibromyalgia had worse clinical postoperative outcomes; two retrospective studies
reported a higher opioid prescription in patients with fibromyalgia and one prospective observational
study found that a higher fibromyalgia survey score correlated with lower quality of recovery scores
two days after surgery. The scarce and low-quality evidence available does not allow confirming
that fibromyalgia has an impact on postoperative outcomes in shoulder surgery. Future studies
specifically focusing on shoulder surgery outcomes may help improvement and personalization of
the management of patients with fibromyalgia syndrome (PROSPERO 2019, CRD42019121180).
Keywords: fibromyalgia; shoulder; surgery; arthroscopy; arthroplasty
1. Introduction
Fibromyalgia is a musculoskeletal syndrome characterized by chronic widespread pain and
systemic manifestations such as fatigue, non-refreshed sleep, mood disturbance, and cognitive
impairment, causing a high impact on health-related quality of life (HRQoL) [1,2]. Although the
prevalence in the general population is approximately 3%, ranging from 0.4% to 9.3% worldwide,
fibromyalgia is often misdiagnosed, with patients waiting up to two years for a definitive diagnosis [3,4].
The pathogenesis of fibromyalgia seems to be due to the complex interaction of the “central sensitization”
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with the “peripheral sensitization”. The “central sensitization” is the increased responsiveness of
neurons of the central nociceptive pathways by low-threshold, non-noxious inputs such as pressure
and temperature [5,6]. The “peripheral sensitization” is the reduction of threshold and the increase
in responsiveness of the peripheral nociceptors probably associated with a reduction in epidermal
small-fiber density [7,8]. Consequently, patients with fibromyalgia report more pain than normally
expected based on the type or degree of stimulus [2,5].
The diagnosis of fibromyalgia is not straightforward because physical examination in these
patients is often non-specific, apart from diffuse tenderness. A relevant limit is that actually no specific
instrumental test for fibromyalgia is validated and used in clinical practice. Therefore, classification
criteria based on history or physical examination have been developed (Table 1) [9,10].
The treatment of fibromyalgia includes a multidisciplinary approach, based on individual
needs [11].
Table 1. Fibromyalgia diagnostic criteria—2016 revision.
Widespread Pain Index (WPI)
Left upper region (Region 1)  Right upper region (Region 2) 
 Jaw * 
 Shoulder girdle 
 Upper arm 
 Lower arm 
Left lower region (Region 3)  Right lower region (Region 4) 
 Hip (buttock, trochanter) 
 Upper leg 
 Lower leg 
Axial region (Region 5)
Neck 
Upper back 
Lower back 
Chest or breast * 
Abdomen * 
Total score (0-19): ______
Symptom Severity Scale (SS) score
0 1 2 3
Fatigue    
Waking unrefreshed    
Cognitive symptoms    
Present
Headaches 
Pain/cramps in lower abdomen 
Depression 
Total score (0-12): ______
For Widespread Pain Index (WPI): note the number of areas and the number of regions in which the patient has
had pain over the last week. For the symptom severity scale (SSS) score: for each of the 3 symptoms (fatigue,
waking unrefreshed, and cognitive symptoms) indicate the level of severity over the past week using the following
scale: 0 = no problem; 1 = slight or mild problems, generally mild or intermittent; 2 = moderate, considerable
problems, often present and/or at a moderate level; 3 = severe: pervasive, continuous, life-disturbing problems.
SSS is the sum of the severity scores of the 3 symptoms (0–9) plus the sum (0–3) of the score of the presence of the
following symptoms the patient refers over the past 6 months: (1) headaches; (2) pain or cramps in lower abdomen;
(3) depression. Fibromyalgia severity scale is the sum of WPI and SSS. Criteria are satisfied if all conditions are met:
(1) WPI ≥ 7 and SSS score ≥ 5 or WPI 4–6 and SSS score ≥ 9. (2) Generalized pain, defined as pain in at least 4 of 5
regions. (3) Symptoms generally present for at least 3 months. (4) A diagnosis of fibromyalgia does not exclude the
presence of other clinically important illnesses. * Jaw, chest, and abdominal pain are not included in generalized
pain definition.
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Although the most common complaint of patients with fibromyalgia is “pain all over the body”,
some patients may refer to the orthopedic surgeon for pain localized in a specific region. Shoulder
pain is reported to be one of the most frequent localizations in fibromyalgia, after back pain and neck
pain [12].
Fibromyalgia evaluation scales are not routinely assessed by orthopedic surgeons, with a high
risk of misdiagnosis of this pathology, which may even coexist in patients with other pathological
conditions such as cuff tears or osteoarthritis [13,14]. Medical or surgical options are often performed
in these patients, with the risk of unexplained unsatisfactory results, considering that several studies
found that fibromyalgia patients may require different postoperative pain management [15–17].
A higher opioid consumption in these patients undergoing lower-extremity joint replacement has
been demonstrated [15,18], but to date there is a lack of knowledge about the effects on upper limb
orthopedic surgery [19,20].
The aim of this systematic review is to search the currently available literature regarding the
influence of fibromyalgia on clinical outcomes of patients undergoing surgery for shoulder pain.
2. Materials and Methods
A systematic literature review was performed from November 2018 to February 2019 without
a time limit following the PRISMA statement for transparent reporting of systematic reviews and
meta-analyses [21]. The following participants, interventions, comparisons, outcomes, and study design
(PICOS) were used: adult patients undergoing surgery for shoulder pain (P); diagnosis of fibromyalgia
(I); patients without fibromyalgia (C); outcome of surgery in terms of pain or analgesic or non-steroidal
anti-inflammatory drugs (NSAID) consumption (O); case series, retrospective studies, observational
studies, open-label studies, randomized clinical trials. Systematic reviews and meta-analyses were
included to extract primitive studies (S).
Database search included PubMed/Medline, Embase, and ClinicalTrials.gov. Only articles written
in English were selected. PubMed database was searched for the terms (“fibromyalgia” [MeSH Terms]
OR “fibromyalgia” [All Fields]) AND (“shoulder” [MeSH Terms] OR “shoulder” [All Fields]). Embase
database was searched for the terms (“fibromyalgia”/exp OR fibromyalgia) AND (“shoulder”/exp OR
shoulder). ClinicalTrials.gov was searched for the terms “fibromyalgia” AND “shoulder”. Exclusion
criteria applied in this review were articles in a different language other than English, case reports,
commentaries, letters to the editor and biomechanical studies. All studies were analyzed using title
and abstract, and then the full text was collected to establish the coherence with the PICOS of this
review. These steps were performed by two different authors (RG and FL) and controversies were
resolved after discussion. When an agreement was not achieved, a third researcher (RC) was involved
to give a final unanimous selection.
A bias assessment was performed according to the Cochrane handbook guidelines to give a
clear strength of clinical indications of this review (allocation, blinding, attrition, reporting, and other
potential sources of bias) in selected randomized controlled trials, if available [22]. For all other studies,
the free software Review Manager (RevMan 5.3) was used to asses all these biases. In particular,
for non-randomized observational studies, we used the Newcastle–Ottawa quality assessment scale [23].
The protocol has been submitted to the PROSPERO registry (https://www.crd.york.ac.uk/prospero,
registration number CRD42019121180).
3. Results
Authors found 678 articles using the described research strategies (193 articles in PubMed/Medline
and 485 in Embase). Thirty-six clinical trials were identified in ClinicalTrials.gov. Duplicates were
recognized and deleted using the EndNote program, reaching the number of 559 articles. Two authors
were able to identify further duplicates performing a manual crosscheck using the names of authors,
title and DOI number, reaching a final number of 523 articles (Figure 1).
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No randomized controlled studies were found applying the PICOS planned for this review.
Results of this research did not find studies designed to compare two different cohorts of patients.
However, authors found three retrospective observational studies and one prospective observational
study which considered fibromyalgia among risk factors of postoperative surgical outcomes (Table 2).
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Figure 1. Flowchart of the study.
The study by Blonna et al. was aimed to retrospectively evaluate the prevalence of fibromyalgia in
a cohort of consecutive patients attending the shoulder and elb w service of a single center [24]. Patients
with a final diagnosis of fibromyalgia were 18 out of 286 (6.3%). These pati nts were subsequently asked
to co lete a shoulder questi nnaire, the new Oxford shoulder (OS) scor , a quality of life q estionnaire,
the short form-12 (SF-12), and a global Summary Outcome Determination score (SOD score). Authors
found that, among the 18 patients finally diagnosed with fibromyalgia, only five had already received
a diagnosis of fibromyalgia or received a diagnosis of fibromyalgia during the first appointment, with
the remaining 13 patients diagnosed during one of the follow-up examinations. At the first evaluation,
four patients received a diagnosis of rotator cuff tears, seven received a diagnosis of subacromial
bursitis, one received a diagnosis of calcific tendin tis, and thre received a diagnosis of adhesive
capsulitis, whereas three patients ha fibromyalgia as a single diagno is. After an average follow-up
time of 15 months, 56% of patients reported having severe symptoms with the OS score and 44% had
mild to moderate symptoms.
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Based on the SOD score, one patient stated that the shoulder was worse than before the treatment,
56% of patients reported that shoulder symptoms were unchanged, 28% reported some improvement,
and 11% reported great improvement. None of the patients reported that the shoulder was normal
or almost normal. Five patients received a total of 11 surgeries for shoulder pain, and among these,
one patient was treated after the diagnosis of fibromyalgia was made. In the other four patients,
fibromyalgia was misdiagnosed. All of these patients reported mild to severe symptoms at the
last follow-up.
Conclusions are that orthopedics should be aware that fibromyalgia could be the cause of failure
in the treatment of concomitant painful shoulder [24].
The study by Cheng et al. was aimed to determine whether preoperative pain history or the
fibromyalgia survey score could predict shoulder arthroscopy outcomes, such as pain and physical
functioning and postoperative consumption of opioids [25].
Table 2. Summary and comparison of search results.
Author StudyDesign Sample Size
Type of
Intervention Outcomes Conclusions
Follow-Up
Time
Blonna et al.
[24]
Retrospective
observational
286 patients,
including 18 with
fibromyalgia,
of which
5 underwent
surgery (11 joints)
Orthopedic
evaluation
for shoulder
pain and
shoulder
surgery
Diagnosis of
fibromyalgia,
new OSS, SF-12,
and global
SOD score
Fibromyalgia may be a
cause of failure in the
treatment of
concomitant painful
shoulder.
15 months
(range:
12–27 months)
Cheng et al.
[25]
Prospective
observational 100 patients
Any type of
shoulder
arthroscopy
Opioid
consumption,
pain scores,
neuropathic pain
(PainDETECT),
physical
functioning
(PROMIS), Quality
of Recovery-9
A higher FSS does not
correlate with
postoperative opioid
consumption, but with
a lower 2nd-day
postoperative Quality
of Recovery-9 score.
14 days
Westermann
et al. [26]
Retrospective
case control
35,155 shoulder
arthroscopies,
including 7884
with myalgia or
fibromyalgia
Arthroscopy
for rotator
cuff repair
Postoperative
opioid
prescriptions
Significantly more
opioid prescriptions in
fibromyalgia patients
12 months
Rao et al.
[27]
Retrospective
large
database
analysis
4243 surgery
procedures in
3996 patients,
including 92 with
fibromyalgia
Elective
shoulder
arthroplasty
Postoperative
opioid
consumption
Higher opioid
prescription in patients
with fibromyalgia in the
later rehabilitation
period
360 days
FSS: fibromyalgia survey score, OSS: Oxford shoulder score, SF-12: short form-12; SOD: summary outcome determination.
One hundred shoulder arthroscopy patients completed preoperative validated self-reported
measures of different variables such as pain and depressive symptoms and the fibromyalgia survey
score, generated by the sum of the widespread pain index and symptom severity scale and ranging
from 0 to 31 [9]. Outcomes were assessed on postoperative day two (opioid consumption, pain, physical
functioning, and quality of recovery score) and 14 (opioid consumption and pain). Subjects were
divided into tertiles for univariate analyses, which were referred to as “very low” (0–2), “low” (3–6),
and “moderate” (7–13) groups. After multivariate modeling, authors observed that the fibromyalgia
survey score was not associated with postoperative pain or opioid consumption. However, they found
a significant correlation (p = 0.001) with the quality of recovery as assessed by the Quality of Recovery-9
scale after 2 days.
The study by Westermann et al. aimed to define opioid consumption and to evaluate patient
factors that could be associated with prolonged opioid use after arthroscopy performed for rotator
cuff repair (RCR) in the U.S. [26]. During the study period, 35,155 arthroscopic RCRs were studied.
Authors reported that patients with fibromyalgia were more likely to be prescribed opioid medications
after RCR, with a three-month follow-up risk ratio (RR) of 1.67 and a 95% confidence interval (CI) of
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1.6–1.75, reaching a 12-month follow-up RR of 2.16 (95% CI: 2.03–2.31). Based on these results, authors
recommended preoperative counseling of patients with this diagnosis.
The study by Rao et al. was based on the retrospective analysis of a large database with the goal
of identifying patient risk factors for opioid use after shoulder arthroplasty [27]. The study sample
consisted of 4243 shoulder arthroscopies performed in 3996 patients. Of these, 92 had a diagnosis of
fibromyalgia (2.4% of the population). The primary outcome of the study was the number of dispensed
opioid prescriptions for a post-operative follow-up of 360 days, divided in quarters of 90 days each:
Q1, days 0–90; Q2, days 91–180; Q3, days 181–270; and Q4, days 271–360. Fibromyalgia was reported
among the risk factors associated with higher opioid use during the Q4 follow-up (later rehabilitation
period), with a reported incidence rate ratio of 1.20 (95% CI: 1.04–1.38).
The high heterogeneity among the included studies regarding study design and outcomes
measured did not allow for a meta-analysis. Specific differences in study design and patient selection
are summarized in Table 2 and the bias assessment is reported in Table 3.
4. Discussion
The results of this review demonstrate a severe lack of evidence regarding the influence of
fibromyalgia in patients undergoing surgery for shoulder pain, without randomized or non-randomized
controlled trials analyzing this aspect. Three retrospective observational studies and one prospective
observational study were identified. Non-randomized observational studies in general provide a low
quality of evidence [22]. Furthermore, none of the studies were designed to directly compare two
different cohorts (patients with fibromyalgia syndrome vs. patients without fibromyalgia syndrome).
Finally, the risk of bias due to several study limitations further reduces the quality of evidence.
In particular, the study by Blonna et al. [24] is a retrospective study, and therefore baseline OS and SF-12
scores before treatment are not available; furthermore, only 5 patients with fibromyalgia underwent
surgery, and therefore, sound conclusions regarding its influence on outcomes of surgery cannot be
drawn. However, this is the first study exploring if fibromyalgia may have an impact on surgical
outcomes in the shoulder and demonstrating that it is often misdiagnosed by orthopedics. The study
by Cheng et al. [25] is the first to analyze fibromyalgia survey scores in a prospective design. However,
it has several limitations, including the exclusion of patients who were already on chronic opioid therapy
before surgery, the lack of an adjustment for confounding factors, and the very short follow-up periods
(2 and 14 days), which limits the external validity of the results. In the study by Westermann et al. [26],
the prevalence of fibromyalgia/myalgia patients in this study is around 22%, which is much higher than
that in the other studies included in our systematic review. This is likely due to the fact that authors
included patients with an International Classification of Diseases, Ninth Revision (ICD-9) code 729.1,
which includes patients with a diagnosis of myalgia, fibromyalgia, or myositis. Classification criteria
for fibromyalgia are not specified in the Methods section. Similarly, in the study by Rao et al. [27],
no criteria for the diagnosis of fibromyalgia are reported, thus reducing the external validity of these
results. Overall, our rate of confidence in the results of the studies included is low (Table 3).
Although the aim of our review was to find evidence on a very specific topic, i.e., the influence of
fibromyalgia syndrome on surgical outcomes in patients with shoulder diseases requiring an orthopedic
evaluation, the results are consistent with a lack of evidence. These findings do not necessarily mean a
lack of correlation between worse surgical outcome and fibromyalgia syndrome. Indeed, we expect
that a significant prevalence of fibromyalgia in patients referring to orthopedic surgeons for shoulder
pain may emerge with specifically designed studies addressing this topic, based on the highly reported
prevalence of fibromyalgia syndrome in the general population [3], on the evidence that the shoulder
is among the most frequently affected regions in fibromyalgia syndrome [12], and on the evidence
coming from lower-extremity joint replacement patients [15,18,28] and from other specialties such as
gynecologic surgery [16,17].
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Table 3. Newcastle–Ottawa assessment scale scores for the included studies.
Newcastle–Ottawa Quality Assessment Scale
Selection Comparability Outcome
Author Representativeness ofthe Exposed Cohort
Selection of the
Non-Exposed
Cohort
Ascertainment of
Exposure
Demonstration
that Outcome of
Interest Was Not
Present at the Start
of Study
Comparability
of Cohorts on
the Basis of the
Design or
Analysis
Assessment of
Outcome
Was Follow-Up
Long Enough
for Outcome to
Occur?
Adequacy of
Follow Up of
Cohorts
Blonna et al.
[24] Truly representativeF n/a Surgical recordsF YesF n/a
Self-reported
outcomes and
medical recordsF
YesF n/a
Cheng et al. [25] Truly representativeF n/a Surgical recordsF YesF n/a
Self-reported
outcomes and
medical recordsF
No n/a
Westermann
et al. [26]
Fibromyalgia diagnosis
based on ICD-9 n/a Surgical recordsF YesF n/a Medical recordsF YesF n/a
Rao et al. [27] No description offibromyalgia criteria n/a Surgical recordsF YesF n/a Medical recordsF YesF n/a
ICD-9: International Classification of Diseases, Ninth Revision; n/a: not applicable because not studies comparing different cohorts.
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5. Conclusions
The results of this systematic review demonstrate that limited evidence is currently available
on the influence of fibromyalgia on clinical outcomes after shoulder surgery. Overall, patients with
fibromyalgia undergoing surgery seem to be at risk of an increased use of analgesic drugs. The presence
of a shoulder disease does not exclude the diagnosis of fibromyalgia, and orthopedic surgeons should
be aware of this condition when approaching a patient with shoulder pain.
Future studies should be designed to specifically address the impact of fibromyalgia in shoulder
surgical outcomes, evaluating postoperative pain and long-term follow-up with specific shoulder
evaluation scales.
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